AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
The firm scrapped its £450m investment despite the government's offer of support, the government says.
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the ...
AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...
Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...
AstraZeneca has cancelled a multi-million pound investment in a vaccine plant in Merseyside because the government failed to ...
1d
Daily Independent on MSNAstraZeneca reaffirms commitment to cancer care on World Cancer Day 2025In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...
A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...
AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...
1d
Pharmaceutical Technology on MSNAstraZeneca lung cancer therapy Imfinzi recommended for EU approvalEMA's CHMP has recommended AstraZeneca's Imfinzi for approval in the EU as a single agent for limited-stage small cell lung ...
DUBAI, UAE - Media OutReach Newswire - 28 January 2025 - AstraZeneca, a leading multinational pharmaceutical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results